Best International Stocks To Own For 2015

Trading in the Chinese yuan has picked up significantly in recent years.

NEW YORK (CNNMoney) The Chinese yuan was the ninth most traded currency in the world in the most recent ranking by the Bank for International Settlements, the first time the currency has broken into the top 10.

The Chinese government has traditionally worked to keep the currency pegged to the dollar as a way of promoting manufacturing in its export-driven economy. That has prompted charges by critics that it is involved in currency manipulation.

Pressure from other nations has led the Chinese government to allow more movement in the value of the yuan in recent years, which in turn has increased the trading activity.

The currency was involved in 2.2% of foreign exchange trading worldwide in April, the period examined by this week's report. That's more than twice the share of the foreign exchange trading it participated in April 2010. The dollar was involved in 87% of all trades, the euro was part of 33% of trades, and the Japanese yuan was involved in 23%.

Best International Stocks To Own For 2015: Gevo Inc (GEVO)

Gevo, Inc., incorporated in June 2005, is a renewable chemicals and advanced biofuels company. The Company is focused on the development and commercialization of alternatives to petroleum-based products. The Company operates in two segments: Gevo, Inc. Segment and Gevo Development/Agri-Energy Segment. Gevo, Inc. Segment is responsible for all research and development activities related to the future production of isobutanol, maintaining and protecting its intellectual property portfolio, developing future markets for its isobutanol and providing corporate oversight services. Its Gevo Development/Agri-Energy Segment is responsible for the production of ethanol and related products. In September 2010, the Company acquired a 22 MGPY ethanol production facility in Luverne, Minnesota that the Company intends to retrofit to produce isobutanol.

The Company�� isobutanol can also be converted by its customers into a range of hydrocarbons, which form the basis for the production of many products, including plastics, fibers, rubber and other polymers and hydrocarbon fuels, including jet and diesel fuel. Its technology platform consists of biocatalysts and a isobutanol separation unit. Together these technologies form the Gevo Integrated Fermentation Technology (GIFT). GIFT is designed to allow relatively low capital expenditure retrofits of existing ethanol facilities, enabling isobutanol production from a range of renewable feedstocks. The Company�� biocatalysts are microorganisms that have been designed to metabolize sugars to produce isobutanol.

GIFT consists of two components, biocatalysts which convert sugars derived from multiple renewable feedstocks into isobutanol through fermentation, and a separation unit which is designed to continuously separate isobutanol from water during the fermentation process. The Company developed its technology platform to be compatible with the existing approximately 20 BGPY of global operating ethanol production capacity, as estimated by the R! enewable Fuels Association (RFA).

The Company competes with Butamax Advanced Biofuels LLC (Butamax), BP p.l.c. (BP), E. I. du Pont de Nemours and Company, Butalco GmbH, Cathay Industrial Biotech Ltd., METabolic EXplorer S.A., TetraVitae Bioscience, Inc., Cobalt Technologies, Inc., Green Biologics Ltd. Shell Oil Products US (Shell Oil), BP, DuPont-Danisco Cellulosic Ethanol LLC, Abengoa Bioenergy, S.A., POET, LLC, ICM, Mascoma, Range Fuels, Inbicon A/S, INEOS New Planet BioEnergy LLC, Coskata, Archer Daniels Midland Company, BlueFire Ethanol, Inc., KL Energy Corporation, ZeaChem Inc., Iogen Corporation, Qteros, Inc., and AE Biofuels, Inc.

Advisors' Opinion:

• [By Bryan Murphy]

  The so-called fundamentals, frankly, don't really matter for Entest BioMedical Inc. (OTCMKTS:ENTB) or Gevo, Inc. (NASDAQ:GEVO). Oh, both GEVO and ENTB are generating sales, but both are consistently taking losses. That's ok though, as for both companies right now, profits aren't really the point - it's the pipeline that matters.

Best International Stocks To Own For 2015: Luxottica Group SpA (LUX)

Luxottica Group S.p.A. (Luxottica), incorporated in 1961, is an Italy-based company engaged in the design, manufacture and distribution of prescription frames and sunglasses in the mid-and premium-price categories. It operates in two segments: manufacturing and wholesale distribution and retail distribution. Through its manufacturing and wholesale distribution segment, it is engaged in the design, manufacture, wholesale distribution and marketing of house and designer lines of mid-to premium-priced prescription frames and sunglasses. The Company operates its retail segment principally through its retail brands, which include, among others, LensCrafters, Pearle Vision, Sears Optical, Target Optical and its Licensed Brands (Sears Optical and Target Optical), as well as through the retail brands of its business, Oakley, which include, among others, Oakley O Stores and Vaults, David Clulow e nel segmento Licensed Brand. Among its subsidiaries there are: Air Sun, Bazooka Inc, David Clulow Brighton Ltd and Ecotop Pty Ltd.

In May 2010, the Company acquired a 35.16% interest held by minority stockholders in Luxottica Gozluk Endustri ve Ticaret Anonim Sirketi, (Luxottica Turkey). On July 30, 2010, Luxottica acquired a 34% interest held by minority stockholders in Sunglass Hut (UK) Limited. On November 26, 2010, it acquired the Optifashion Australia Pty Limited group from HAL Optical Investments B.V. The acquisition included 47 corporate stores (40 optical and seven sun) and nine franchises, trading under brands including Just Spectacles. During the year ended December 31, 2010, the Company completed the acquisition of the David Clulow chain, bringing its ownership in the subsidiary to 100%. Luxottica�� house brands include Ray-Ban, Oakley, Arnette, Persol, REVO, Vogue, Oliver Peoples, K&L, Luxottica, Mosley Tribes, Sferoflex and Eye Safety Systems (ESS). Its licensed designer brands include Anne Klein, Brooks Brothers, Bvlgari, Burberry, Chanel, Dolce & Gabbana, D&G, Donna Karan, DKNY, Fox, Miu ! Miu, Paul Smith, Polo Ralph Lauren, Prada, Salvatore Ferragamo, Stella McCartney, Tiffany & Co, Tory Burch and Versace. Polo Ralph Lauren includes Chaps, Polo, Ralph and Ralph Lauren Purple Label. Product design, development and manufacturing takes place in six production facilities in Italy, two wholly owned factories in China and two sports sunglasses production facilities in the United States. Luxottica also has a small plant in India serving the local market.

During 2010, the Company produced approximately 56.6 million units. In North America, the Company operates the points of sale for its Licensed Brands, with over 1,140 stores under the Sears Optical and Target Optical brands. During 2010, it distributed approximately 20.4 million prescription frames and approximately 38.4 million sunglasses, in approximately 5,900 different styles. During 2010, it announced the signing of a license agreement with Coach, Inc. (Coach) for the design, manufacturing and global distribution of sun and prescription eyewear under the Coach, Coach Poppy and Reed Krakoff brands. Essilor S.A. (Essilor) is the supplier of the Company�� retail operations.

Luxottica�� distribution system is globally integrated and supplied by a centralized manufacturing programming platform. The network linking the logistics and sales centers to the production facilities in Italy and China also provides daily monitoring of global sales performance and inventory levels so that manufacturing resources can be programmed and warehouse stocks re-allocated to meet local market demand. This integrated system serves both the retail and wholesale businesses with 18 distribution centers worldwide, of which eight are in the Americas, seven are in the Asia-Pacific region and three are in the rest of the world. It has three main distribution centers (hubs) in locations serving its markets: Sedico in Europe, Atlanta in the Americas and Dongguan in the Asia-Pacific region. They operate as centralized facilities, offering custo! mers a au! tomated order management system. During 2010, it managed over 13,500 orders per day, including eyeglasses and spare parts. Sedico ships over 170,000 units daily to customers in Europe, the Middle East and Africa and to its distribution centers in the rest of the world, from which they are then shipped to local customers.

Wholesale Distribution

The Company�� wholesale distribution network, covering 130 countries across five continents, has 18 logistics centers and 42 commercial subsidiaries providing direct operations in key markets. Luxottica also distributes certain brands, including Oakley, to sporting goods stores and specialty sports stores, including bike, surf, snow, skate, golf and motor sports stores.

Retail Distribution

The retail portfolio offers a range of differentiation points for consumers, including the latest in designer and sun frames, lens options, eye care and everyday vision care health benefits. As of March 31, 2011, the Company�� retail business consisted of 5,911 corporate stores and 514 franchised or licensed locations. In its retail sun business, Luxottica operates over 2,480 retail locations in North America, Asia-Pacific, South Africa, Europe and the Middle East, mainly through the Sunglass Hut brand. Luxottica�� retail stores sells not only prescription frames and sunglasses that it manufactures but also a range of prescription frames, lenses and other ophthalmic products manufactured by other companies. During 2010, units manufactured with its brand names or its licensed brands represented approximately 80.2% of the total sales of frames based on units sold by the retail division.

Luxottica�� optical retail operations are anchored by brands, such as LensCrafters and Pearle Vision in North America, and OPSM, Laubman & Pank and Budget Eyewear, which are available in Australia and New Zealand. It also has a retail presence in China, where the Company operates in the eyewear market with LensCrafters. As of ! March 31,! 2011, the Company�� optical retail business consisted of approximately 3,650 retail locations globally. As of March 31, 2011, it operated a retail network of 1,191 LensCrafters stores, of which 989 are in North America and 202 stores are in China and Hong Kong. LensCrafters stores offer a range of selection of prescription frames and sunglasses, mostly made by Luxottica, in addition to a range of lenses and optical products made by other suppliers. LensCrafters' products include lenses, such as FeatherWates (lightweight, thin and impact-resistant lenses), DURALENS (super scratch-resistant lenses), Advanced View Progressive (free-form, digitally surfaced progressive lenses), Invisibles (anti-reflective lenses) and MVP Maximum View Progressives (multi-focal lenses without visible lines).

Pearle Vision is a optical retail chain in North America. As of March 31, 2011, Pearle Vision operated 330 corporate stores and had 350 franchise locations throughout North America. The Company also operates a network of retail locations in North America operating as Sears Optical and Target Optical, its Licensed Brands, which uses the brand names of their respective American department store. As of March 31, 2011, it operated 828 Sears Optical and 323 Target Optical locations throughout North America. OPSM includes three optical chains that it operates in Australia and New Zealand. In July 2010, the brand launched its new flagship store OPSM Eye Hub and in September 2010, the brand launched its new OPSM Loves Eyes marketing campaign. As of March 31, 2011, the Company owned 357 OPSM corporate stores throughout Australia. OPSM also has 43 corporate-owned stores in New Zealand, mainly in large urban areas.

Laubman & Pank focuses on the independent optical shopper looking for eyecare and service. As of March 31, 2011, Luxottica owned 65 Laubman & Pank corporate stores throughout Australia. As of March 31, 2011, the Company owned 92 Budget Eyewear corporate stores throughout Australia and had nine! franchis! e locations. Budget Eyewear also has 14 corporate stores in New Zealand. EyeMed Vision Care is a managed vision care operators in the United States, serving over 28.5 million members in large and medium size companies and government entities and through insurance companies. EyeMed has a network of over 24,000 locations, including opticians, ophthalmologists, optometrists and chains operated by Luxottica. Together with LensCrafters' over 900 in-store labs, Luxottica operates five central lens finishing labs in North America. In addition, it operates Oakley optical lens laboratories in the United States, Ireland and Japan. As of March 31, 2011, Sunglass Hut had 2,385 stores worldwide, of which 2,329 are corporate stores and 56 are franchise locations. As of March 31, 2011, the Company operated approximately 590 Sunglass Hut departments in Macy's.

ILORI is Luxottica's fashion sunwear retail brand, with 24 stores in North America, as of March 31, 2011, including flagship stores in the SoHo neighborhood of New York City and in Beverly Hills, California. As of March 31, 2011, the Company operated 24 Optical Shop of Aspen stores in locations throughout the United States. Luxottica operates six luxury retail stores under the Oliver Peoples brand. The Oliver Peoples brand retail stores only offer Oliver Peoples, Mosley Tribes and Paul Smith branded optical products. Two additional Oliver Peoples retail locations are operated under license in Tokyo and Los Angeles. In Europe, it operates David Clulow, an optical retailer operating in the United Kingdom and Ireland. As of March 31, 2011, David Clulow operated 39 corporate-owned locations (including nine joint ventures), four franchise locations and 36 sun stores/concessions. As of March 31, 2011, Bright Eyes operated 51 corporate store locations and 73 franchise locations. As of March 31, 2011, the Company operated 159 Oakley O Stores and Vaults worldwide, offering a range of Oakley products, including sunglasses, apparel, footwear and accessories. An! other sal! es channel is e-commerce, including the Oakley and the Ray-Ban Websites (www.oakley.com, www.Ray-Ban.com).

The Company competes with De Rigo S.p.A., Marchon Eyewear, Inc., Marcolin S.p.A., Safilo Group S.p.A., Silhouette International Schmied AG, Maui Jim, Inc., Wal-Mart, Eye Care Centers of America, Vision Service Plan (VSP), Davis Vision and Spectera.

Advisors' Opinion:

• [By Roberto Pedone]

  First up is $25 billion eyewear stock Luxottica Group (LUX). Luxottica has posted some solid performance year-to-date, rallying more than 28% since the calendar flipped over to January. But this stock looks downright toxic right now. Here's why.

  Luxottica is currently forming a bearish price setup called a descending triangle. The pattern is formed by a horizontal support level below shares at $51 and downtrending resistance to the topside. As shares bounce between those two technically significant price levels, LUX is getting squeezed closer to a breakdown below that $51 price floor. When that happens, we've got our sell signal in this fashion stock.

  Declining volume over the course of the setup in LUX adds some confirmation to the trade, but the downtrend in relative strength is the real problem in this chart. LUX has been underperforming the broad market horrifically in the last quarter, and a move through the $51 level would sap a lot more buying pressure from shares.

  If you still own LUX, look for that sell signal as your exit.

Best Managed Healthcare Stocks To Invest In 2015: Rosetta Genomics Ltd (ROSG)

Rosetta Genomics Ltd., incorporated on March 9, 2000, is seeking to develop and commercialize diagnostic tests based on discovered group of genes known as microRNAs. The Company has established a clinical laboratory improvement amendment (CLIA)-certified laboratory in Philadelphia, which enables it to develop, validate and commercialize its own diagnostic tests applying its microRNA technology. In July 2011, the Company launched its fifth product - miRview lung. As of December 31, 2011, the Company launched five tests based on its five microRNA technologies: miRview mets; miRview mets2; miRview squamous; miRview meso, and miRview lung.

Rimonim Consortium

In January 2011, the Company joined the Rimonim Consortium, which is supported by the Office of the Chief Scientist at the Ministry of Industry, Trade and Labor of the State of Israel, or the OCS. The purpose of the consortium is to develop RNA interference, or RNAi, -based therapeutics.

Rosetta Green

Rosetta Green Ltd. is an Israeli subsidiary of the Company, which was established to leverage its capabilities into the areas of cleantech and plant biotech by using its microRNA technologies to develop plants and algae more suitable for various applications, such as feedstocks for biofuels and agriculture. Research at the Rosetta Green project has been shown to develop algal strains with oil content, to discover potential novel microRNAs from commercially-important algae and to identify drought-regulated microRNAs in plants.

The Company competes with Pathwork Diagnostics, Inc., Biotheranostics, Inc., Combimatrix Corporation, Alnylam Pharmaceuticals, Inc., Asuragen Inc., Exiqon A/S, Life Technologies Corporation, Isis Pharmaceuticals, Merck & Co., Inc., Santaris Pharma A/S, and Regulus Therapeutics.

Advisors' Opinion:

• [By Anthony Mirhaydari]

  For now, I continue to recommend investors maintain a cautious stance, focusing on the buying interest coming into safe-haven assets like U.S. Treasury bond and precious metals while booking profits in biotech stocks that have been red hot this month. The leveraged Direxion 3x Treasury Bond Bull (TMF) is up nearly 7% in my Edge Letter Sample Portfolio since it was added on Jan. 10. I just sold Tower Hill Mines (THM) and Rosetta Genomics (ROSG) for gains of 46% and 18% respectively.

• [By John Udovich]

  Small cap genomics stocks Rosetta Genomics Ltd (NASDAQ: ROSG), Genomic Health, Inc (NASDAQ: GHDX) and CollabRx Inc (NASDAQ: CLRX) are at the forefront of genomics testing�or research. I should mention that Wikipedia defines genomics�as a�discipline in genetics that applies recombinant DNA, DNA sequencing methods and bioinformatics to sequence, assemble and analyze the function and structure of genomes (the complete set of DNA within a single cell of an organism). A 2013 Booz Allen Hamilton report on the sector noted that in�2011, the US genetic and genomic clinical testing market size was estimated to be $5.9 billion while the�number of available tests has grown substantially from 1,680 just 4 years ago to 2,886 in 2012.

• [By John Udovich]

  On Tuesday, small cap cancer diagnostic stock Myriad Genetics, Inc (NASDAQ: MYGN) jumped 11.42% in one day, meaning its worth taking a closer look at the stock along with the performance of small cap cancer diagnostic stocks like Rosetta Genomics Ltd (NASDAQ: ROSG) and�Genomic Health, Inc (NASDAQ: GHDX) plus mid cap diagnostic stock Quest Diagnostics Inc (NYSE: DGX). I should mention that we have had�Myriad Genetics in our SmallCap Network Elite Opportunity (SCN EO) portfolio since February 5th and we are already up 18.50%���a nice return in just two weeks time.

• [By John Udovich]

  Small cap cancer diagnostic stock�Myriad Genetics, Inc (NASDAQ: MYGN) jumped to a five year high on Wednesday�thanks to good�news that the�government will be paying a heftier reimbursement for its main test than previously feared, meaning its worth taking a closer look at the stock along with small cap cancer diagnostic stocks like Rosetta Genomics Ltd (NASDAQ: ROSG) and�Genomic Health, Inc (NASDAQ: GHDX) plus mid cap diagnostic stock Quest Diagnostics Inc (NYSE: DGX). I should also mention that Myriad Genetics has been in our SmallCap Network Elite Opportunity (SCN EO) portfolio since early February and we are now up some 32.5% since then ��thanks in part to the shorts being put in a short squeeze.

Best International Stocks To Own For 2015: Molina Healthcare Inc (MOH)

Molina Healthcare, Inc., incorporated on July 24, 2002, provides medicaid-related solutions. The Company operates in two segments: Health Plans and Molina Medicaid Solutions. The Company's Health Plans segment consists of health plans in California, Florida, Michigan, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin, and includes the Company's direct delivery business. The Company's Molina Medicaid Solutions segment provides design, development, implementation, and business process outsourcing solutions to state governments for their Medicaid Management Information Systems (MMIS).As of December 31, 2012, Health Plans segment served approximately 1.8 million members eligible for Medicaid, Medicare, and other government-sponsored health care programs for low-income families and individuals. In June 2013, Molina Healthcare Inc announced that, through its wholly owned subsidiary, Molina Center LLC, it has successfully completed a sale and lease back transaction with the dedicated net lease group of Angelo, Gordon & Co (AG).

The health plans are operated by the Company's wholly owned subsidiaries in those states, each of which is licensed as a health maintenance organization (HMO). The Company's direct delivery business consists of 24 primary care clinics in California, Florida, New Mexico, and Washington, and the Company manages three county-owned primary care clinics under a contract with Fairfax County, Virginia. The Company's Health Plans segment derives its revenue principally in the form of premiums received under Medicaid contracts with the states in which the Company's health plans operate. All of the Company's health plans operate on a single managed care platform for claims processing (the QNXT 4.8 system). MMIS is a core tool used to support the administration of state Medicaid and other health care entitlement programs. Molina Medicaid Solutions holds MMIS contracts with the states of Idaho, Louisiana, Maine, New Jersey, and West Virginia, as well as a contract to provide d! rug rebate administration services for the Florida Medicaid program. The Company arranges health care services for its members through contracts with providers that include independent physicians and groups, hospitals, ancillary providers, and its own clinics. The Company's network of providers includes primary care physicians, specialists and hospitals. The Company contracts with both primary care physicians and specialists many of whom are organized into medical groups or independent practice associations (IPAs).

The Company develops specialized disease management programs that address the particular health care needs of its members. motherhood matters! sm is a comprehensive program designed to improve pregnancy outcomes and enhance member satisfaction. breathe with ease! is a multi-disciplinary disease management program that provides health education resources and case management services to assist physicians caring for asthmatic members between the ages of three and 15. Healthy Living with Diabetes is a diabetes disease management program. Heart Health Living is a cardiovascular disease management program for members who have suffered from congestive heart failure, angina, heart attack, or high blood pressure. The Company provides its members with information to guide them through various episodes of care. This information, which is available in several languages, is designed to educate parents on the use of primary care physicians, emergency rooms, and nurse call centers. The Company's pharmacy management programs focus on physician education regarding appropriate medication utilization and encouraging the use of generic medications. The Company's pharmacists and medical directors work with the Company's pharmacy benefits manager to maintain a formulary that promotes both improved patient care and generic drug use. The Company provides certain centralized medical and administrative services to its health plans pursuant to administrative services agreements, including medical affairs a! nd qualit! y management, health education, credentialing, management, financial, legal, information systems, and human resources services.

The Company competes with HP Enterprise Services, ACS, Computer Services Corporation, and CNSI.

Advisors' Opinion:

• [By Seth Jayson]

  Molina Healthcare (NYSE: MOH  ) reported earnings on April 25. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended March 31 (Q1), Molina Healthcare met expectations on revenues and crushed expectations on earnings per share.

• [By Sean Williams]

  If you want a ray of sunshine in this mess, look no further than either WellPoint (NYSE: WLP  ) or Molina Healthcare (NYSE: MOH  ) . Both companies have a stronghold in California with WellPoint's Blue Cross Blue Shield and Molina's low-cost and Medicaid-sponsored plans offering ample choices in the early going for consumers. Although early enrollment in California was disappointing, the expectation all along has been that it would pick up as we get closer to coverage enrollment cutoff date. With few signs of exchange problems in California I'd look for these two companies to impress investors moving forward.

Best International Stocks To Own For 2015: Solutia Inc(SOA)

Solutia Inc. and its subsidiaries manufacture performance materials and specialty chemicals used in various consumer and industrial applications. The company?s Advanced Interlayers segment provides polyvinyl butyral (PVB) sheet that is used in the manufacture of laminated glass for automotive and architectural applications, and as an encapsulant in photovoltaic applications primarily under the SAFLEX name; ethyl vinyl acetate films under the VISTASOLAR name for photovoltaic module encapsulation; and specialty intermediate PVB resin and plasticizer products under the BUTVAR name. Its Performance Films segment manufactures solar control, decorative, safety and security window films for aftermarket automotive and architectural applications under the LLUMAR, V-KOOL, H�ER OPTIK, VISTA, GILA, and FORMULA ONE HIGH PERFORMANCE AUTOMOTIVE TINT names; and advanced film components that are used in electronics and energy industrial products under the FLEXVUE name. The company?s Te chnical Specialties segment manufactures and sells chemicals for the rubber, solar energy, process manufacturing, and aviation industries. This segment offers insoluble sulfur under the CRYSTEX name; and antidegradants, which are used in pneumatic tire components, solid tires, belts, hoses, cables, automotive mounts, bushings, and general mechanical products under the SANTOFLEX name. This segment also provides heat transfer fluids that are used for indirect heating or cooling of chemical processes in various types of industrial equipment and in solar energy power systems under the THERMINOL name; and aviation hydraulic fluids for airline airframe manufacturers and aviation maintenance facilities under the SKYDROL name. The company sells its products to end users in various industries through distributors and franchisees, as well as through its sales force in the United States, Europe, the Asia Pacific, and internationally. Solutia Inc. was founded in 1901 and is headquartere d in St. Louis, Missouri.

Advisors' Opinion:

• [By Holly LaFon]

  His largest new buys in the first quarter are: Penn Virginia Group Holdings LP (PVG), Wynn Resorts Ltd. (WYNN), Methanex Corp. (MEOH), Solutia Inc. (SOA) and Georgia Gulf (GGC). Of his top eight stocks, five are from the chemicals industry.

Best International Stocks To Own For 2015: Network Exploration Ltd (NET)

Network Exploration Ltd. is an exploration and development-stage company. The Company�� principal business activities include the exploration of minerals in its mineral properties. It focuses on base and precious metal properties in North and South America. Its activities include the process of exploring its mineral properties, reviewing and subsequently acquiring mineral properties and conducting exploration programs to determine whether these properties contain ore reserves that are recoverable. The Picha copper-silver project is located within the Tertiary Volcanic Arc of Southern Peru. The Pistala project is located east of the NW-SE trending Incapquio fault system in the Department of Tacna, Southern Peru. The Company is in the business of mineral exploration in Canada, Chile and Peru. Network Exploration Chile Limitada is its wholly owned subsidiary. Advisors' Opinion:

• [By Damian Illia]

  Although the company is overly relying on Afrezza, there is to say that MannKind has inked some deals in the recent past. These were primarily aimed to furthering its pipeline development but with less risk and with less research and development expenditure directly for the firm. In November, 2012 it signed a license agreement with Colby Pharmaceutical Company granting the latter exclusive rights to its early stage cancer program. Currently, the firm is also looking for partners regarding Afrezza. Last year in July, it entered one with Deerfield that ensured financing worth $160 million for MannKind. Also, in October 2012, the company raised $86 million (net) through the issuance of shares and has almost $120 million left under its credit facility. This has removed some concerned about a financial crisis in the company, although it hasn't done so throughly.

• [By Holly LaFon]

  MSCI All Country World Index (Net) is an unmanaged index comprised of 44 country indices comprising 23 developed and 21 emerging market country indices and is calculated with dividends reinvested after de duction of withholding tax. The Index is a trademark of Morgan Stanley Capital International and is not available for direct investment.

Best International Stocks To Own For 2015: Time Warner Cable Inc(TWC)

Time Warner Cable Inc., together with its subsidiaries, operates as a cable operator in the United States. It offers video, high-speed data, and voice services over its broadband cable systems to residential and commercial customers. The company provides a range of video services, including on-demand, high-definition (HD), and digital video recorder (DVR) services; residential high-speed data services with connection to the Internet; wireless mobile broadband Internet services; and digital phone services to residential customers. It offers video programming tiers and music services; high-speed data, networking, and transport services; and commercial digital phone service to small and medium-sized businesses under the Time Warner Cable Business Class brand. Further, Time Warner Cable Inc. sells advertising to various national, regional, and local customers. As of June 30, 2011, the company served approximately 14.5 million residential and commercial customers in the New Yor k State, the Carolinas, Ohio, southern California, and Texas. Time Warner Cable Inc. is based in New York, New York.

Advisors' Opinion:

• [By Travis Hoium]

  Intel (NASDAQ: INTC  ) is reportedly willing to pay big to become a player in streaming television, hoping to upend the cable industry. This could change the monopoly market conditions Comcast (NASDAQ: CMCSA  ) and Time Warner (NYSE: TWC  ) have built in cable and it may open up the industry for streaming companies like Apple (NASDAQ: AAPL  ) and Netflix (NASDAQ: NFLX  ) as well. Fool contributor Travis Hoium tell investors what he thinks of Intel's big bet in the video below.�